Image

Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease

Study on genetic risk of immune response after transfusions in sickle cell patients.

Recruiting
2-99 years
All
Phase N/A
**Study Summary** This study aims to understand why some people with **Sickle Cell Disease (SCD)** have an immune reaction when they receive a blood transfusion. A blood transfusion is when you receive blood from another person. The immune reaction is called an *alloimmune response*. Researchers believe that this response is linked to changes in our genes, which are tiny instructions in our cells that tell our body how to work. By comparing genes of those who have an alloimmune response to those who don't, scientists hope to find ways to improve treatments. **Key Points:** - **Length & Visits:** Participation involves gene analysis; the details on visits or length aren't specified. - **Eligibility:** Participants must have SCD, be over 2 years old, and meet specific transfusion history or genetic criteria. - **Exclusions:** People with impaired decision-making, transplants, on certain medications, or pregnant cannot join. This research could lead to better care for people with SCD who have reactions to blood transfusions.
Study details
    Sickle Cell Disease

NCT06944067

National Human Genome Research Institute (NHGRI)

10 October 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.